Aquestive Therapeutics shares are trading higher after HC Wainwright & Co and Leerink Partners raised their respective price targets on the stock.
Portfolio Pulse from Benzinga Newsdesk
Aquestive Therapeutics shares rose following price target increases by HC Wainwright & Co and Leerink Partners.
September 30, 2024 | 4:34 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aquestive Therapeutics shares increased due to raised price targets by HC Wainwright & Co and Leerink Partners, indicating positive analyst sentiment.
The increase in price targets by two reputable firms suggests a positive outlook for Aquestive Therapeutics, likely boosting investor confidence and driving the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100